176 related articles for article (PubMed ID: 37791598)
41. Apolipoprotein E4 inhibits autophagy gene products through direct, specific binding to CLEAR motifs.
Parcon PA; Balasubramaniam M; Ayyadevara S; Jones RA; Liu L; Shmookler Reis RJ; Barger SW; Mrak RE; Griffin WST
Alzheimers Dement; 2018 Feb; 14(2):230-242. PubMed ID: 28945989
[TBL] [Abstract][Full Text] [Related]
42. Apolipoprotein E mediates attachment of clinical hepatitis C virus to hepatocytes by binding to cell surface heparan sulfate proteoglycan receptors.
Jiang J; Wu X; Tang H; Luo G
PLoS One; 2013; 8(7):e67982. PubMed ID: 23844141
[TBL] [Abstract][Full Text] [Related]
43. ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease.
Li Y; Macyczko JR; Liu CC; Bu G
Neurobiol Aging; 2022 Jul; 115():20-28. PubMed ID: 35453035
[TBL] [Abstract][Full Text] [Related]
44. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice.
Kunzler J; Youmans KL; Yu C; Ladu MJ; Tai LM
Neurosci Lett; 2014 Feb; 560():131-6. PubMed ID: 24368217
[TBL] [Abstract][Full Text] [Related]
45. Calcium-dependent cytosolic phospholipase A
Wang S; Li B; Solomon V; Fonteh A; Rapoport SI; Bennett DA; Arvanitakis Z; Chui HC; Miller C; Sullivan PM; Wang HY; Yassine HN
Mol Neurodegener; 2021 Apr; 16(1):26. PubMed ID: 33863362
[TBL] [Abstract][Full Text] [Related]
46. APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.
Fernández-Calle R; Konings SC; Frontiñán-Rubio J; García-Revilla J; Camprubí-Ferrer L; Svensson M; Martinson I; Boza-Serrano A; Venero JL; Nielsen HM; Gouras GK; Deierborg T
Mol Neurodegener; 2022 Sep; 17(1):62. PubMed ID: 36153580
[TBL] [Abstract][Full Text] [Related]
47. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex.
Arold S; Sullivan P; Bilousova T; Teng E; Miller CA; Poon WW; Vinters HV; Cornwell LB; Saing T; Cole GM; Gylys KH
Acta Neuropathol; 2012 Jan; 123(1):39-52. PubMed ID: 22020632
[TBL] [Abstract][Full Text] [Related]
48. Absence of ApoE upregulates murine brain ApoD and ABCA1 levels, but does not affect brain sterol levels, while human ApoE3 and human ApoE4 upregulate brain cholesterol precursor levels.
Jansen PJ; Lütjohann D; Thelen KM; von Bergmann K; van Leuven F; Ramaekers FC; Monique M
J Alzheimers Dis; 2009; 18(2):319-29. PubMed ID: 19584433
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 Lipidation.
Valencia-Olvera AC; Balu D; Faulk N; Amiridis A; Wang Y; Pham C; Avila-Munoz E; York JM; Thatcher GRJ; LaDu MJ
Neurotherapeutics; 2023 Jul; 20(4):1120-1137. PubMed ID: 37157042
[TBL] [Abstract][Full Text] [Related]
50. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
Marais AD
Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
[TBL] [Abstract][Full Text] [Related]
51. VEGF Mediates ApoE4-Induced Neovascularization and Synaptic Pathology in the Choroid and Retina.
Antes R; Salomon-Zimri S; Beck SC; Garcia Garrido M; Livnat T; Maharshak I; Kadar T; Seeliger M; Weinberger D; Michaelson DM
Curr Alzheimer Res; 2015; 12(4):323-34. PubMed ID: 25817253
[TBL] [Abstract][Full Text] [Related]
52. New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E.
Libeu CP; Lund-Katz S; Phillips MC; Wehrli S; Hernáiz MJ; Capila I; Linhardt RJ; Raffaï RL; Newhouse YM; Zhou F; Weisgraber KH
J Biol Chem; 2001 Oct; 276(42):39138-44. PubMed ID: 11500500
[TBL] [Abstract][Full Text] [Related]
53. Concerning the structure of apoE.
Frieden C; Garai K
Protein Sci; 2013 Dec; 22(12):1820-5. PubMed ID: 24115173
[TBL] [Abstract][Full Text] [Related]
54. Apolipoprotein E expression and purification.
Newhouse Y; Weisgraber KH
Methods Mol Biol; 2011; 670():127-40. PubMed ID: 20967588
[TBL] [Abstract][Full Text] [Related]
55. The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer's Disease.
Safieh M; Liraz O; Ovadia M; Michaelson D
J Alzheimers Dis; 2024; 97(2):753-775. PubMed ID: 38217595
[TBL] [Abstract][Full Text] [Related]
56. Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease?
Lozupone M; Imbimbo BP; Balducci C; Lo Vecchio F; Bisceglia P; Latino RR; Leone M; Dibello V; Solfrizzi V; Greco A; Daniele A; Watling M; Seripa D; Panza F
Alzheimers Dement; 2023 Jan; 19(1):353-368. PubMed ID: 35900209
[TBL] [Abstract][Full Text] [Related]
57. Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples.
Tai LM; Bilousova T; Jungbauer L; Roeske SK; Youmans KL; Yu C; Poon WW; Cornwell LB; Miller CA; Vinters HV; Van Eldik LJ; Fardo DW; Estus S; Bu G; Gylys KH; Ladu MJ
J Biol Chem; 2013 Feb; 288(8):5914-26. PubMed ID: 23293020
[TBL] [Abstract][Full Text] [Related]
58. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.
Ji ZS; Fazio S; Mahley RW
J Biol Chem; 1994 May; 269(18):13421-8. PubMed ID: 8175773
[TBL] [Abstract][Full Text] [Related]
59. Sex and APOE Genotype Alter the Basal and Induced Inflammatory States of Primary Microglia from APOE Targeted Replacement Mice.
Mhatre-Winters I; Eid A; Han Y; Tieu K; Richardson JR
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077227
[TBL] [Abstract][Full Text] [Related]
60. Isoform-specific proteolysis of apolipoprotein-E in the brain.
Elliott DA; Tsoi K; Holinkova S; Chan SL; Kim WS; Halliday GM; Rye KA; Garner B
Neurobiol Aging; 2011 Feb; 32(2):257-71. PubMed ID: 19278755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
